Stay updated on ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    This updates the displayed interface/version identifier on the page (revision v3.5.0 → v3.5.3).
    Difference
    0.0%
    Check dated 2026-04-26T15:18:44.000Z thumbnail image
  4. Check
    49 days ago
    Change Detected
    Summary
    Added Waldenström macroglobulinemia, Richter syndrome, and B-cell chronic lymphocytic leukemia to the conditions section, and updated site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-28T22:45:07.000Z thumbnail image
  5. Check
    70 days ago
    Change Detected
    Summary
    The page now displays revision number v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T12:46:49.000Z thumbnail image
  6. Check
    92 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2; no other changes to content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T16:28:52.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    - The page revision was updated from v3.4.0 to v3.4.1 (added v3.4.1 and removed v3.4.0).
    Difference
    0.1%
    Check dated 2026-02-06T10:43:21.000Z thumbnail image
  8. Check
    114 days ago
    Change Detected
    Summary
    UI updates include adding Show glossary and Hide glossary controls, and introducing new labels such as 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted' in Study Record Dates, while removing older labels like 'Last Update Submitted that met QC Criteria' and 'Last Update Posted (Estimated)'. Footer/meta updates include adding 'No FEAR Act Data' and 'Revision: v3.4.0', while removing 'No FEAR Act data' and 'Revision: v3.3.4'; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-22T18:07:26.000Z thumbnail image

Stay in the know with updates to ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196 + Pembrolizumab in Hematologic Malignancies Clinical Trial page.